Short sequence reads from 23 isolates of five different species, Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, Staphylococcus aureus and Vibrio cholerae, were also submitted to ResFinder. All 23 isolates had been sequenced on the Illumina platform using paired-end reads. A ResFinder threshold of ID = 98.00% was selected, as previous tests of ResFinder had shown that a threshold lower than this gives too much noise (e.g. fragments of genes). Phenotypic antimicrobial susceptibility testing was determined as MIC determinations, as previously described.8 (link)With ‘(chromosome and plasmid)(multi-drug or antimicrobial or antibiotic)(resistant or resistance) pathogen’ as search criteria, one isolate from each species with completely sequenced and assembled, and chromosome and plasmid data were collected from the NCBI Genomes database (
Salmonella enterica
It is a common inhabitant of the intestinal tract of many animals, including humans, and can lead to a range of diseases such as salmonellosis, enteric fever, and bacteremia.
Salmonella enterica includes over 2,500 serovars, with Salmonella Typhimurium and Salmonella Enteritidis being the most prevalent and clinically significant.
This bacterium is an important area of research, as understanding its pathogenesis, epidemiology, and antimicrobial resistance patterns is crucial for developing effective prevention and treatment strategies.
PubCompare.ai's AI-driven protocol comparison tool can help optimize Salmonella enterica research by enhancing reproducibility and accuracy, allowing researchers to identify the best protocols and products from literature, preprints, and patents.
Most cited protocols related to «Salmonella enterica»
Short sequence reads from 23 isolates of five different species, Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, Staphylococcus aureus and Vibrio cholerae, were also submitted to ResFinder. All 23 isolates had been sequenced on the Illumina platform using paired-end reads. A ResFinder threshold of ID = 98.00% was selected, as previous tests of ResFinder had shown that a threshold lower than this gives too much noise (e.g. fragments of genes). Phenotypic antimicrobial susceptibility testing was determined as MIC determinations, as previously described.8 (link)With ‘(chromosome and plasmid)(multi-drug or antimicrobial or antibiotic)(resistant or resistance) pathogen’ as search criteria, one isolate from each species with completely sequenced and assembled, and chromosome and plasmid data were collected from the NCBI Genomes database (
Antimicrobial resistance gene detection was performed using the ARG-Annot database of acquired resistance genes [18 (link)]. Allele sequences (DNA) were downloaded in fasta format [43 ] (May, 2014). Sequences were clustered into gene groups with ≥80% identity using CD-hit [44 (link)] and the headers formatted for use with SRST2 using the scripts provided (cdhit_to_csv.py, csv_to_gene_db.py). A copy of the formatted sequence database used in this study is included in the SRST2 github repository [35 ].
Representative sequences for 18 plasmid replicons were extracted from GenBank using the accessions and primer sequences specified by Carattoli et al. [45 (link)]. A copy of the formatted sequence database used in this study is included in the SRST2 github repository [35 ].
As a result of this concatenation procedure, we obtained dramatic space reductions for many species; e.g., the total sequence was reduced from 661 to 74 Mbp (11% of the original sequence size) in S. enterica and from 655 to 107 Mbp (16%) in E. coli (see
Most recents protocols related to «Salmonella enterica»
Example 1
Plasmodium glutamine synthetase has not been examined as a target for antimalarial development. PlasmoDB (plasmodb.org/plasmo/app/), a functional genomic database for malaria parasites reveals that P. falciparum possesses only a single GS gene in the genome (Gene ID: PF3D7_0922600). There are three distinct groups of glutamine synthetases. Type I (GS-I, encoded by glnA) and type II (GS-II, glnII) are the predominant forms in prokaryotes and eukaryotes, respectively. Type III (GS-III, glnN) was recently recognized in a few prokaryotes and eukaryotes. A phylogenetic analysis of representative parasite GS from seven phyla and one division was conducted (
Species were identified using MALDI-TOF (Vitek MS, bioMeriéux, Nürtingen, Germany) and the identity of Salmonella strains was confirmed by serotyping using group-specific and monospecific antisera (Sifin Diagnostics, Berlin, Germany) according to the White-Kauffmann-Le Minor scheme.
Top products related to «Salmonella enterica»
More about "Salmonella enterica"
This Salmonella spp. is a common inhabitant of the intestinal tract of many animals, including humans, and can lead to a range of diseases such as salmonellosis, enteric fever, and bacteremia.
Salmonella enterica includes over 2,500 serovars, with Salmonella Typhimurium and Salmonella Enteritidis being the most prevalent and clinically significant.
This Salmonella pathogen is an important area of research, as understanding its pathogenesis, epidemiology, and antimicrobial resistance patterns is crucial for developing effective prevention and treatment strategies.
Researchers can utilize techniques like pulsed-field gel electrophoresis (PFGE) using the CHEF Mapper system, S1 nuclease digestion, and whole-genome sequencing to study the genetic diversity and relatedness of Salmonella enterica isolates.
Comparisons can also be made to other major bacterial pathogens like Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Enterococcus faecalis to better understand the unique features and challenges of Salmonella research.
Additionally, Bacillus cereus, another foodborne pathogen, shares some similarities in terms of its ability to form spores and survive in the environment.
PubCompare.ai's AI-driven protocol comparison tool can help optimize Salmonella enterica research by enhancing reproducibility and accuracy, allowing researchers to identify the best protocols and products from literature, preprints, and patents.
This innovative platform can be a valuable resource for improving Salmonella research and advancing our understanding of this important public health concern.